Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children.
Ivermectin is a broad-spectrum antiparasitic agent used for the treatment and control of neglected tropical diseases. In Australia, ivermectin is primarily used for scabies and is licensed in children aged ≥5 years weighing >15 kg. However, young children, aged <5 years, are particularly vulne...
Saved in:
Main Authors: | Amanda Gwee (Author), Stephen Duffull (Author), Xiao Zhu (Author), Steven Y C Tong (Author), Noel Cranswick (Author), Brett McWhinney (Author), Jacobus Ungerer (Author), Joshua Francis (Author), Andrew C Steer (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trialResearch in context
by: Amanda Gwee, et al.
Published: (2024) -
Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community.
by: Thérèse M Kearns, et al.
Published: (2015) -
Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.
by: Suny Coscione, et al.
Published: (2018) -
Ivermectin efficacy still imprecise for scabies treatment
by: Antoine Mahé, et al.
Published: (2009) -
Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
by: Gabriela A Willis, et al.
Published: (2023)